Lisata Therapeutics Inc (LSTA)

[Viperciara]

I far as I know all results have been very good so far! The completion date is listed as December 16th. That could change or they could get fast tracked. Here is the page on clinical trials for CLBS10 https://clinicaltrials.gov/ct2/show/NCT01495364

You can also see the resuts so far

PreSERVE 6- and 12-month Interim Conclusions*
•CD34 cell dose-dependent trend in reduced major adverse cardiac events (MACE)
•Reduced serious adverse events (SAEs) frequency trend in higher CD34 cell dose groups (12 month data)
•No deaths in the CLBS10 treated group (12 month data)
•CD34 cell dose-dependent trend in improved left ventricular ejection fraction (LVEF) and in reduced infarct size
•No correlation between experimental endpoint of perfusion and treatment

* Based on data collected at 6 months except where noted

Taken together, these preliminary results suggest that CLBS10 positively impacts the preservation of myocardial function and the prevention of adverse events post-STEMI. The favorable clinical outcomes encourage continued development. For more details, please visit the trial's listing on clinicaltrials.gov.